BioNote, Inc. (KRX:377740)
5,150.00
-20.00 (-0.39%)
Last updated: Apr 29, 2026, 2:16 PM KST
BioNote Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Market Capitalization | 522,332 | 554,446 | 480,684 | 433,228 | 874,096 | - | Upgrade
|
| Market Cap Growth | 10.11% | 15.35% | 10.95% | -50.44% | - | - | Upgrade
|
| Enterprise Value | 186,170 | 207,970 | 83,431 | 16,432 | 174,842 | - | Upgrade
|
| Last Close Price | 5170.00 | 5242.42 | 4330.73 | 3729.89 | 7538.85 | - | Upgrade
|
| PE Ratio | - | - | 8.70 | - | 2.84 | - | Upgrade
|
| PS Ratio | 4.41 | 4.69 | 4.68 | 4.81 | 1.82 | - | Upgrade
|
| PB Ratio | 0.35 | 0.37 | 0.29 | 0.28 | 0.55 | - | Upgrade
|
| P/TBV Ratio | 0.35 | 0.37 | 0.30 | 0.28 | 0.55 | - | Upgrade
|
| P/FCF Ratio | 83.31 | 88.43 | 10.13 | - | 4.23 | - | Upgrade
|
| P/OCF Ratio | 36.32 | 38.55 | 8.30 | - | 3.51 | - | Upgrade
|
| EV/Sales Ratio | 1.57 | 1.76 | 0.81 | 0.18 | 0.37 | - | Upgrade
|
| EV/EBITDA Ratio | 7.15 | 7.99 | 4.09 | - | 0.58 | - | Upgrade
|
| EV/EBIT Ratio | 11.08 | 12.37 | 6.83 | - | 0.59 | - | Upgrade
|
| EV/FCF Ratio | 29.69 | 33.17 | 1.76 | - | 0.85 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.14 | 0.14 | 0.19 | - | 0.00 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 0.58 | 0.58 | 0.08 | - | 0.01 | 0.00 | Upgrade
|
| Net Debt / Equity Ratio | -0.22 | -0.22 | -0.24 | -0.25 | -0.45 | -0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | -12.91 | -12.91 | -19.68 | 10.14 | -2.39 | -1.03 | Upgrade
|
| Net Debt / FCF Ratio | -53.61 | -53.61 | -8.46 | 48.46 | -3.48 | -1.00 | Upgrade
|
| Asset Turnover | 0.07 | 0.07 | 0.06 | 0.05 | 0.30 | 0.53 | Upgrade
|
| Inventory Turnover | 2.00 | 2.00 | 1.86 | 1.86 | 1.94 | 1.87 | Upgrade
|
| Quick Ratio | 28.69 | 28.69 | 18.20 | 39.35 | 14.94 | 4.84 | Upgrade
|
| Current Ratio | 31.01 | 31.01 | 19.69 | 42.26 | 16.66 | 5.42 | Upgrade
|
| Return on Equity (ROE) | -5.56% | -5.56% | 3.46% | -1.30% | 21.43% | 70.80% | Upgrade
|
| Return on Assets (ROA) | 0.65% | 0.65% | 0.46% | -1.76% | 11.38% | 25.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.33% | 1.40% | 0.77% | -4.62% | 26.34% | 59.77% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.10% | 1.10% | 0.70% | -3.00% | 17.30% | 34.20% | Upgrade
|
| Earnings Yield | -16.75% | -15.78% | 11.50% | -4.73% | 35.21% | - | Upgrade
|
| FCF Yield | 1.20% | 1.13% | 9.87% | -1.88% | 23.66% | - | Upgrade
|
| Payout Ratio | - | - | 36.94% | - | 16.23% | 7.38% | Upgrade
|
| Buyback Yield / Dilution | 0.79% | 0.79% | 0.02% | -8.16% | -0.64% | -0.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.